NCT04437888View on ClinicalTrials.gov

Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

April 5, 2024

Study Completion Date

June 1, 2024

Conditions
Pain, PostoperativeArthroplasty Complications
Interventions
DRUG

Ketamine

Ketamine versus saline placebo will be compared in order to evaluate the effects of Ketamine on patients that are pain catastrophizers

Trial Locations (1)

03766

Dartmouth-Hitchcock, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04437888 - Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty | Biotech Hunter | Biotech Hunter